Table of Contents
<< Previous Issue | Mar 2009 (Vol: 2009, Issue: 3) | Next Issue >> |
- Section: Editorial
-
Biosimilars – a risky bet?
- Section: Features
-
Nycomed Looking for Buyers
-
Is Allergan the Next Takeover Target?
-
Elan’s Shares Rise on Takeover Speculation
- Section: Licensing
-
Pfizer Looks for Growth in Generics and Eyecare
-
Lilly Looks to NeuroSearch to Fill Pipeline Gap
-
Merck Serono and Fast Forward to Speed Multiple Sclerosis Developments
- Section: Mergers & Acquisitions
-
Merck to Merge with Schering-Plough in a US$41.1 B deal
-
Roche Gets Genentech for US$46.8 B
-
Could J&J Trip up the Merck and Schering-Plough Deal?
-
Gilead Rescues CV Therapeutics
- Section: Research & Development
-
Zydus Cadila and Lilly Enter US$300 M Research Pact